Style | Citing Format |
---|---|
MLA | Kashani FR, Torki MK. "Haemovigilance System Quality After Establishment of Patient’S Safety Standards: Quality of Request, Return, Adverse Event Reporting, and Obtaining Informed Consent." International Journal of Pharmaceutical Research, vol. 10, no. 1, 2018, pp. 381-389. |
APA | Kashani FR, Torki MK (2018). Haemovigilance System Quality After Establishment of Patient’S Safety Standards: Quality of Request, Return, Adverse Event Reporting, and Obtaining Informed Consent. International Journal of Pharmaceutical Research, 10(1), 381-389. |
Chicago | Kashani FR, Torki MK. "Haemovigilance System Quality After Establishment of Patient’S Safety Standards: Quality of Request, Return, Adverse Event Reporting, and Obtaining Informed Consent." International Journal of Pharmaceutical Research 10, no. 1 (2018): 381-389. |
Harvard | Kashani FR, Torki MK (2018) 'Haemovigilance System Quality After Establishment of Patient’S Safety Standards: Quality of Request, Return, Adverse Event Reporting, and Obtaining Informed Consent', International Journal of Pharmaceutical Research, 10(1), pp. 381-389. |
Vancouver | Kashani FR, Torki MK. Haemovigilance System Quality After Establishment of Patient’S Safety Standards: Quality of Request, Return, Adverse Event Reporting, and Obtaining Informed Consent. International Journal of Pharmaceutical Research. 2018;10(1):381-389. |
BibTex | @article{ author = {Kashani FR and Torki MK}, title = {Haemovigilance System Quality After Establishment of Patient’S Safety Standards: Quality of Request, Return, Adverse Event Reporting, and Obtaining Informed Consent}, journal = {International Journal of Pharmaceutical Research}, volume = {10}, number = {1}, pages = {381-389}, year = {2018} } |
RIS | TY - JOUR AU - Kashani FR AU - Torki MK TI - Haemovigilance System Quality After Establishment of Patient’S Safety Standards: Quality of Request, Return, Adverse Event Reporting, and Obtaining Informed Consent JO - International Journal of Pharmaceutical Research VL - 10 IS - 1 SP - 381 EP - 389 PY - 2018 ER - |